BRCAura RUO

A histology model to predict germline BRCA1/2 mutations from HR+/HER2- breast cancer images

While gBRCA mutations significantly impact treatment decisions and outcomes in breast cancer, many patients never receive genetic testing. What if you could identify these patients from routine H&E slides?

Discover how Owkin is pioneering AI-driven gBRCA screening with BRCAura RUO —  Get access to the case study below.